...
首页> 外文期刊>Cell death & disease. >Retraction Note: Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma
【24h】

Retraction Note: Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma

机译:回缩说明:Hsa-miR-623抑制人肺腺癌的肿瘤进展

获取原文
           

摘要

The authors have retracted the article [Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma, Cell Death & Disease volume 7, page e2388 (2016), doi 10.1038/cddis.2016.260] because it has recently come to their attention that the A549 cells used in this research were contaminated with Hela cells, which may have altered the outcome of their experiment. The conclusions of this article are therefore unreliable. All authors agree to this retraction.
机译:作者撤回了文章[Hsa-miR-623抑制人肺腺癌的肿瘤进展,细胞死亡与疾病,第7卷,第e2388页(2016),doi 10.1038 / cddis.2016.260],因为最近人们注意到这项研究中使用的A549细胞被Hela细胞污染,这可能改变了他们的实验结果。因此,本文的结论不可靠。所有作者都同意这种撤回。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号